2023
DOI: 10.2147/dddt.s405057
|View full text |Cite
|
Sign up to set email alerts
|

Cardiopulmonary Adverse Events of Remimazolam versus Propofol During Cervical Conization: A Randomized Controlled Trial

et al.

Abstract: Purpose This study aimed to compare the cardiopulmonary safety of remimazolam and propofol in patients undergoing cervical conization. Methods This was a single-blind, parallel, randomized controlled study. A total of 204 patients scheduled for day surgery of cold knife cervical conization received either remimazolam-alfentanil anesthesia (remimazolam group) or propofol-alfentanil anesthesia (propofol group). The primary outcome was the incidence of intraoperative cardi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 37 publications
(45 reference statements)
0
1
0
Order By: Relevance
“…Furthermore, the occurrence of intraoperative hypotension was not provided, though it was defined in their methods section. The recent work in female patients undergoing cervical conization demonstrates that remimazolam-based general anesthesia is associated with a decreased incidence of intraoperative hypotension compared with propofol-based general anesthesia [7]. Most importantly, intraoperative hypotension has been associated with an increased risk of PONV [8].…”
mentioning
confidence: 99%
“…Furthermore, the occurrence of intraoperative hypotension was not provided, though it was defined in their methods section. The recent work in female patients undergoing cervical conization demonstrates that remimazolam-based general anesthesia is associated with a decreased incidence of intraoperative hypotension compared with propofol-based general anesthesia [7]. Most importantly, intraoperative hypotension has been associated with an increased risk of PONV [8].…”
mentioning
confidence: 99%